|
|
Volumn 21, Issue 6, 2003, Pages 1190-1191
|
|
Adjuvant chemotherapy for node-positive breast cancer patients: Which is the reference today? [1]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE;
ANTIBIOTIC AGENT;
ANTIEMETIC AGENT;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EPIRUBICIN;
FLUOROURACIL;
ANTINEOPLASTIC AGENT;
CAF PROTOCOL;
DRUG DERIVATIVE;
PACLITAXEL;
TAC PROTOCOL;
TAXOID;
ADJUVANT THERAPY;
BREAST CANCER;
CANCER PATIENT;
CARDIOTOXICITY;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DISEASE FREE SURVIVAL;
DRUG EFFICACY;
FEBRILE NEUTROPENIA;
FOLLOW UP;
HUMAN;
LETTER;
METASTASIS;
MULTIPLE CYCLE TREATMENT;
OPTIMAL DRUG DOSE;
OVERALL SURVIVAL;
PREMENOPAUSE;
PRIORITY JOURNAL;
PROGNOSIS;
TUMOR VOLUME;
ADJUVANT CHEMOTHERAPY;
BREAST TUMOR;
CONTROLLED CLINICAL TRIAL;
FEMALE;
FRANCE;
LYMPH NODE;
LYMPH NODE METASTASIS;
MIDDLE AGED;
PATHOLOGY;
PHASE 3 CLINICAL TRIAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS, PHASE III;
CYCLOPHOSPHAMIDE;
DISEASE-FREE SURVIVAL;
DOXORUBICIN;
FEMALE;
FLUOROURACIL;
FRANCE;
HUMANS;
LYMPH NODES;
LYMPHATIC METASTASIS;
MIDDLE AGED;
PACLITAXEL;
PROSPECTIVE STUDIES;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL ANALYSIS;
TAXOIDS;
TREATMENT OUTCOME;
|
|
EID: 0037445125
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2003.99.223 Document Type: Letter |
|
Times cited : (14)
|
|
References (3)
|
